Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Berthelet

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cells|April 9, 2014
Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)Jean Berthelet, Laurence Dubrez
Oncotargets and Therapy|October 5, 2013
IAP proteins as targets for drug development in oncologyLaurence Dubrez, Jean Berthelet, Valérie Glorian
Medecine Sciences : M/S|April 2, 2014
[IAP and Rho finally connected]Laurence Dubrez, Arthur Marivin, Jean Berthelet
Medecine Sciences : M/S|February 1, 2012
[IAPs: a central element in the NF-κB activating signaling pathway]Jessy Cartier, Arthur Marivin, Jean Berthelet, et al.
Cells|April 9, 2014
The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular StressArthur Marivin, Jean Berthelet, Stéphanie Plenchette, et al.
Nature Reviews. Cancer|August 18, 2022
Mastering the use of cellular barcoding to explore cancer heterogeneityAntonin Serrano, Jean Berthelet, Shalin H Naik, et al.
Cell Death & Disease|May 26, 2017
HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survivalSonja M Lacher, Julia Bruttger, Bettina Kalt, et al.
Cell Death & Disease|April 9, 2025
Olivia Newton-John Cancer Research Institute 10-year Anniversary Conference - a decade of discovery and translationKatherine Eljammas, Tianming A Li, Liam Neil, et al.
EMBO Reports|March 25, 2017
Apoptosis inhibitor 5 is an endogenous inhibitor of caspase-2Gergely Imre, Jean Berthelet, Jan Heering, et al.
Oncogene|November 18, 2022
cIAP1/TRAF2 interplay promotes tumor growth through the activation of STAT3Baptiste Dumétier, Aymeric Zadoroznyj, Jean Berthelet, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cells|April 9, 2014
Regulation of Apoptosis by Inhibitors of Apoptosis (IAPs)Jean Berthelet, Laurence Dubrez
Oncotargets and Therapy|October 5, 2013
IAP proteins as targets for drug development in oncologyLaurence Dubrez, Jean Berthelet, Valérie Glorian
Medecine Sciences : M/S|April 2, 2014
[IAP and Rho finally connected]Laurence Dubrez, Arthur Marivin, Jean Berthelet
Medecine Sciences : M/S|February 1, 2012
[IAPs: a central element in the NF-κB activating signaling pathway]Jessy Cartier, Arthur Marivin, Jean Berthelet, et al.
Cells|April 9, 2014
The Inhibitor of Apoptosis (IAPs) in Adaptive Response to Cellular StressArthur Marivin, Jean Berthelet, Stéphanie Plenchette, et al.
Nature Reviews. Cancer|August 18, 2022
Mastering the use of cellular barcoding to explore cancer heterogeneityAntonin Serrano, Jean Berthelet, Shalin H Naik, et al.
Cell Death & Disease|May 26, 2017
HMG-CoA reductase promotes protein prenylation and therefore is indispensible for T-cell survivalSonja M Lacher, Julia Bruttger, Bettina Kalt, et al.
Cell Death & Disease|April 9, 2025
Olivia Newton-John Cancer Research Institute 10-year Anniversary Conference - a decade of discovery and translationKatherine Eljammas, Tianming A Li, Liam Neil, et al.
EMBO Reports|March 25, 2017
Apoptosis inhibitor 5 is an endogenous inhibitor of caspase-2Gergely Imre, Jean Berthelet, Jan Heering, et al.
Oncogene|November 18, 2022
cIAP1/TRAF2 interplay promotes tumor growth through the activation of STAT3Baptiste Dumétier, Aymeric Zadoroznyj, Jean Berthelet, et al.
Pageof 3